AHR and neoplasm: This is exemplified by systemic cortisol/GR inducing tumor TDO and kynurenine release to activate the AhR on NK cells and CD8+ T cells, thereby driving cytolytic cell “exhaustion” [54], whilst altering the dynamic metabolic interactions and behaviors of tumor microenvironment cells.